The length of your treatment will depend on factors including your initial weight, your weight loss goals, and how your body responds to the medication
A fully human monoclonal antibody, Cosentyx, which works by targeting and inhibiting the IL-17A cytokine, thereby suppressing the inflammatory pathway, was previously only authorized as a subcutaneous treatment in these indications
Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date always verify current benefits directly with Blue Cross Blue Shield of Alabama before making any decision
Your clinician can advise which is most appropriate based on your medical history, any existing conditions and your weight loss goals
The Nurse Practitioner who has ER and Urgent Care experience, is also able to prescribe and include prescription-only add-ons if needed